Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Apparent diffusion coefficient as a quantitative biomarker for prostate cancer treatment response on a 1.5 Tesla magnetic resonance-linear accelerator: Impact of image registration and acquisition type.
Nair PP, Chick J, Nuixe M, Lecoeur B, Xiao Y, Cooper S, Tree AC, van Houdt PJ, Oelfke U, Wetscherek A. Nair PP, et al. Among authors: tree ac. Phys Imaging Radiat Oncol. 2025 Oct 13;36:100851. doi: 10.1016/j.phro.2025.100851. eCollection 2025 Oct. Phys Imaging Radiat Oncol. 2025. PMID: 41146990 Free PMC article.
Harnessing Radiation Biology to Increase Cancer Cure Rates.
Harrington KJ, Veerapathiran S, Tree AC. Harrington KJ, et al. Among authors: tree ac. Cancer J. 2025 Jul-Aug 01;31(4):e0783. doi: 10.1097/PPO.0000000000000783. Epub 2025 Aug 11. Cancer J. 2025. PMID: 40768304 No abstract available.
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Zamboglou C, Doncker W, Christoforou AT, Arcangeli S, Berlin A, Blanchard P, Bauman G, Campi R, Castro E, Choudhury A, Pra AD, Draulans C, Desai N, Ferentinos K, Francolini G, Gillessen S, Grosu AL, Rivas JG, Hoelscher T, Hruby G, Jereczek-Fossa BA, Kamran S, Kasivisvanathan V, Kishan AU, Kounnis V, Loblaw A, Martin J, Mastroleo F, Merseburger AS, Miszczyk M, Mohamad O, Ost P, Papatsoris A, Peeken JC, Sanguedolce F, Sargos P, Schmidt-Hegemann N, Seibert TM, Shelan M, Siva S, Soeterik TFW, Spratt DE, Stenzl A, Strouthos I, Sutera P, Supiot S, Tilki D, Tran PT, Tree AC, Tward J, Ürün Y, Vapiwala N, Waddle MR, Wegener E, Zilli T, Murthy V, Thieme AH, Spohn S. Zamboglou C, et al. Among authors: tree ac. Radiother Oncol. 2025 Sep;210:111039. doi: 10.1016/j.radonc.2025.111039. Epub 2025 Jul 9. Radiother Oncol. 2025. PMID: 40645505 Review.
Intensity-modulated moderately hypofractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-C): early toxicity results from a randomised, open-label, phase 3, non-inferiority trial.
Tree AC, Hinder V, Chan A, Tolan S, Ostler P, van der Voet H, Kancherla K, Loblaw A, Naismith O, Jain S, Martin A, Price D, Brand D, Chu W, Duffton A, Kelly P, O'Neill B, Staffurth J, Sasso G, Pugh J, Manning G, Brown S, Burnett S, Griffin C, Hall E, van As N; PACE Investigators. Tree AC, et al. Lancet Oncol. 2025 Jul;26(7):936-947. doi: 10.1016/S1470-2045(25)00205-0. Epub 2025 Jun 12. Lancet Oncol. 2025. PMID: 40517778 Free PMC article. Clinical Trial.
HERMES: Randomized Trial of 2-Fraction or 5-Fraction Magnetic Resonance Imaging-Guided Adaptive Prostate Radiation Therapy.
Cooper S, Westley RL, Biscombe K, Dunlop A, Mitchell A, Oelfke U, Nill S, Manning G, Burnett S, Murray J, Wilkins A, Tunariu N, Price D, Adkins A, Pathmanathan A, Bucinskaite G, Hafeez S, Parker C, Ratnakumaran R, Verkooijen H, Alexander S, Herbert T, Hall E, Tree AC. Cooper S, et al. Among authors: tree ac. Int J Radiat Oncol Biol Phys. 2025 Nov 1;123(3):773-782. doi: 10.1016/j.ijrobp.2025.05.008. Epub 2025 May 20. Int J Radiat Oncol Biol Phys. 2025. PMID: 40403882 Free article. Clinical Trial.
125 results